Journal of Innovation in Cardiac Rhythm Management
banner BSC 2024 options

Activity Description
This CME-accredited on-demand archive examines the highly anticipated OPTION clinical trial results presented at AHA Scientific Sessions 2024, which compares the safety and efficacy of Left Atrial Appendage Closure to Oral Anticoagulation Therapy for stroke protection in post-ablation AF patients. The late-breaking clinical trial presentation is accompanied by an engaging panel discussion among the experts, who assess the results, discuss their impact on daily practice, and address attendee-submitted questions.

 

Agenda

tmb BSC 2024 Option Panel  

Access On-Demand Webinar

 

Claiming Credit:
To earn credit upon viewing the video; access the CME Accreditation tab >>, click on the Claim Credit Button, and complete the assessment questions using the online credit tracker form to receive CME credits or Contact Hours. Participants can download or print a certificate once the form has been successfully submitted.

 

Agenda

Welcome and Introductions
David DeLurgio, MD

OPTION Clinical Trial Results
Oussama Wazni, MD

Panel Discussion with Q&A Session
Moderator: David DeLurgio, MD
Panelists: Oussama Wazni, MD, Devi Nair, MD, and Walid Saliba, MD
 

Commercial Support
This activity is supported through an educational grant from Boston Scientific.

Joint Providership:
MediaSphere Medical, LLC and Ciné-Med

 

 

 

Faculty

Moderator

Presenter and Panelist
David DeLurgio MD

David DeLurgio, MD
Emory Heart & Vascular Center
Atlanta, GA

 Oussama Wazni MD

Oussama Wazni, MD
Cleveland Clinic Foundation
Cleveland, OH
 

Panelists
Devi Nair MD

Devi Nair, MD
St. Bernard’s Heart & Vascular Center
Jonesboro, AR

 Walid Saliba

Walid Saliba, MD
Cleveland Clinic Foundation
Cleveland, OH
 

 

    

CME Accreditation

CME Released: 11/22/2024; Valid for credit through 11/22/2025

On-Demand Archive CME Certificate Fulfillment.
To successfully earn credit, participants must complete the activity online during the valid credit period noted above. To receive AMA PRA Category 1 Credits™ or Contact Hours, you must receive a minimum score of 70% on the post-test, accessible on the Claim Credit page. CME/CE certificates are issued to your inbox upon successful completion.

Participants who have claimed credits for live attendance are not eligible also to claim credits through the enduring archive.

Live Activity Certificate Fulfillment
CME Credits are available to claim for attendees of the live activity. 1 certificate is supplied electronically for the cumulative credits earned commensurate with the extent of participation. To claim your credits, click on the Claim Credit button and complete the online Credit and Evaluation form. Once the form has been submitted, participants will be able to download or print a certificate.

Enduring Accredited Archive
The enduring archive of the live activity will be accredited for CME Credits and Contact Hours. Participants who claim credits for live attendance are not eligible to claim credits through the enduring archive.

Target Audience
This activity has been developed to fulfill the educational needs of Electrophysiologists, Cardiologists, Neurologists, Fellows-In-Training, allied healthcare professionals, and other Physician groups interested in managing Atrial Fibrillation patients at a heightened risk of stroke. 

Learning Objectives
Upon completion of this educational activity, participants will be able to:

  • Examine the safety and effectiveness of LAAC to OAC therapy for stroke prevention in post-ablation patients with atrial fibrillation.
  • Evaluate the clinical significance of the findings from the OPTION trial and their applicability in real-world practice settings.

Accreditation Statement
Jointly Accredited Provider TMThis activity has been planned and implemented by MediaSphere Medical and Ciné-Med to improve patient care. Ciné-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Ciné-Med designates this educational activity for a maximum of 1 AMA PRA CATEGORY 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.

Ciné-Med designates this activity for 1 Contact Hours for Nurses.

Disclosure Policy
MediaSphere Medical and Ciné-Med adhere to accreditation requirements concerning industry support of continuing medical education. Speakers must openly disclose any limitations of data and any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. Speakers will disclose any relationships at the beginning of their presentations.

All MediaSphere Medical and Ciné-Med employees in content control have indicated that they have no relevant financial relationships to disclose.

MediaSphere Medical and Ciné-Med policy is to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real or apparent conflicts of interest held within the past 12 months.

MediaSphere Medical and Ciné-Med implement a mechanism to identify and resolve all conflicts of interest before delivering the educational activity to learners.

Non-Endorsement Statement
MediaSphere Medical and Ciné-Med verify that sound education principles have been demonstrated in developing this educational offering, as evidenced by reviewing its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Ciné-Med do not endorse or support the actual opinions or material content presented by the speaker(s) and sponsoring organization.

Commercial Support
This activity is supported through an educational grant from Boston Scientific.

Joint Providership:
MediaSphere Medical, LLC and Ciné-Med

Claim CME

CME/CE Test
  1. Please complete the following CME/CE post-test. Your submission will be reviewed and notification provided shortly regarding certificate fulfillment status. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

  2. First Name: *  
    Invalid Input
  3. Last Name: *  
    Invalid Input
  4. Primary Email Address: *  
    Invalid Input
  5. Confirm Your Email: *  
    Invalid Input
  6. Degree: *  
    Invalid Input
  7. Specialty:*  
    Invalid Input
  8. Institution: *  
    Invalid Input
  9. Mailing Address:*  
    Invalid Input
  10. City: *  
    Invalid Input
  11. State: *  
    Invalid Input

  12. 1) Three-year results from the OPTION clinical trial, comparing the WATCHMAN FLX (Boston Scientific) left atrial appendage closure (LAAC) system to oral anticoagulation for stroke reduction in patients with non-valvular atrial fibrillation (AF), show that the device was associated with a lower risk of bleeding and non-inferior for all-cause death, stroke or systemic embolism.
  13. Select one*  


    Invalid Input Please Select one

  14. 2) WATCHMAN FLX met the primary efficacy endpoint of all-cause death, stroke, or systemic embolism at 36 months, with the data showing non-inferiority of the device to oral anticoagulation (5.4% vs. 5.8%; p<0.0001).
  15. Select one*  


    Invalid Input Please Select one

  16. 3) Limitations of the OPTION Clinical Trial?
  17. Select one*  





    Invalid Input Please Select one

  18. 4) Clinical Implications of the OPTION Clinical Trial?
  19. Select one*  




    Invalid Input Please Select one

  20. Although optional, we respectfully request that you complete the activity evaluation form, since your feedback assists in the development of future educational activities.

  21. Background

    Please rate each question using a scale of 1 to 5 (1 = Beginner, 5 = Advanced)


  22. I would consider my level of expertise in the subject matter prior to the webcast as:
    Invalid Input Please Select one

  23. I would consider my level of expertise in the subject matter after the activity:
    Invalid Input

  24. Considering my experience and background, the material presented was:
    Invalid Input Please Select one

  25. Extent to which activity met the identified objectives
    Please rate each question using a scale of 1 to 5 (1 = Not Met, 5 = Completely Met)

  26. Examine the safety and effectiveness of LAAC to OAC therapy for stroke prevention in post-ablation patients with atrial fibrillation.
    Invalid Input Please Select one

  27. Evaluate the clinical significance of the findings from the OPTION trial and their applicability in real-world practice settings.
    Invalid Input Please Select one

  28. Information Presented
    Please evaluate the information that was presented by answering Yes, No, Maybe or Not Applicable

  29. Reinforced my current practice/treatment habits:
    Invalid Input Please Select one

  30. Will improve my practice/patient outcomes:
    Invalid Input Please Select one

  31. Enhanced my current knowledge base:
    Invalid Input Please Select one

  32. Provided new ideas or information that I expect to use:
    Invalid Input Please Select one

  33. Information gained from this conference will result in making a change in your practice:
    Invalid Input Please Select one

  34. Future activities on this subject matter is important to my practice:
    Invalid Input Please Select one

  35. Addressed a professional practice gap:
    Invalid Input Please Select one

  36. Was free of commercial bias/influence:
    Invalid Input Please Select one

  37. What barriers do you anticipate in incorporating best practices learned in this activity into clinical activities or quality improvement initiatives at your institution?
    Invalid Input

  38. What mechanisms can you identify to overcome these barriers?
    Invalid Input

  39. (*) Required Fields
  40. Invalid Input

Suggested Reading

Original Article

New England Journal of Medicine

Left Atrial Appendage Closure after Ablation for Atrial Fibrillation
Authors: Oussama M. Wazni, M.D., Walid I. Saliba, M.D., Devi G. Nair, M.D., Eloi Marijon, M.D., Ph.D., Boris Schmidt, M.D., Troy Hounshell, D.O., Henning Ebelt, M.D., Carsten Skurk, M.D., Saumil Oza, M.D., Chinmay Patel, M.D., Arvindh Kanagasundram, M.D., Ashish Sadhu, M.D., Sri Sundaram, M.D., Jose Osorio, M.D., George Mark, M.D., Madhukar Gupta, M.D., David B. DeLurgio, M.D., Jeffrey Olson, D.O., Jens Erik Nielsen-Kudsk, M.D., D.M.Sc., Lucas V.A. Boersma, M.D., Ph.D., Jeff S. Healey, M.D., Karen P. Phillips, M.B., B.S., Federico M. Asch, M.D., Katherine Wolski, M.P.H, Kristine Roy, Ph.D., Thomas Christen, M.D., Ph.D., Brad S. Sutton, M.D., Kenneth M. Stein, M.D., and Vivek Y. Reddy, M.D., for the OPTION Trial Investigators*

 

 

*By clicking on the Access button, you will be redirected to an external, not affiliated site.

 

 

 

 

 

 

Editorial Board | Author Guidelines | About Us | Contact Us | Submit Manuscript | Subscribe | Terms of Use | Privacy Policy

505 South Lenola Road, Suite 121, Moorestown, NJ 08057

  Copyright © 2011-2025  MediaSphere Medical LLC.  All Rights Reserved.   

Website Design Internet Marketing by DigitalSequence